(-)-CP 47,497 |
| Katalog-Nr.GC18694 |
CP 47,497 is a bicyclic cannabinoid analog with potent analgesic activity.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 114753-51-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CP 47,497 is a bicyclic cannabinoid analog with potent analgesic activity. [1] It is comparable or more potent than Δ9-tetrahydrocannabinol in analgesic, motor depressant, anticonvulsant and hypothermic effects in mice, rats, and dogs. [2] The levorotatory enantiomer, (-)-CP 47,497 avidly binds the CB1 receptor (Ki = 2.1 nM).[3]
Reference:
[1]. Melvin, L.S., Johnson, M.R., Harbert, C.A., et al. A cannabinoid derived prototypical analgesic. Journal of Medicinal Chemistry 27, 67-71 (1984).
[2]. Weissman, A., Milne, G.M., and Melvin, L.S., Jr. Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. Journal of Pharmacology and Experimental Therapeutics 223(2), 516-523 (1982).
[3]. Melvin, L.S., Milne, G.M., Johnson, M.R., et al. Structure-activity relationships defining the ACD-tricyclic cannabinoids: Cannabinoid receptor binding and analgesic activity. Drug Design and Discovery 13, 155-166 (1995).
Average Rating: 5 (Based on Reviews and 40 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *